CymitQuimica logo

CAS 379-79-3

:

Ergotamine tartrate

Description:
Ergotamine tartrate is a pharmaceutical compound derived from ergot alkaloids, primarily used in the treatment of migraine headaches. It is a semi-synthetic derivative of ergotamine, which is obtained from the fungus Claviceps purpurea. This compound is characterized by its ability to constrict blood vessels, thereby alleviating migraine symptoms. Ergotamine tartrate is typically administered in the form of tablets or sublingual formulations, allowing for rapid absorption and onset of action. The substance is known for its potential side effects, including nausea, vomiting, and cardiovascular complications, particularly when used inappropriately or in excessive doses. It acts primarily as a selective agonist for serotonin receptors, particularly the 5-HT1B and 5-HT1D subtypes, which play a crucial role in regulating vascular tone and neurotransmitter release. Due to its pharmacological properties, ergotamine tartrate is classified as a controlled substance in some jurisdictions, necessitating careful monitoring and prescription by healthcare professionals.
Formula:C33H35N5O5C4H6O6
InChI:InChI=1S/C33H35N5O5.C4H6O6/c1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32;5-1(3(7)8)2(6)4(9)10/h3-6,8-11,15,17,21,25-27,34,42H,7,12-14,16,18H2,1-2H3,(H,35,39);1-2,5-6H,(H,7,8)(H,9,10)/t21-,25-,26+,27+,32-,33+;1-,2-/m11/s1
InChI key:InChIKey=NMTWKEWYQXZGCI-LYOWLMOVSA-N
SMILES:O[C@@]12N([C@@H](CC3=CC=CC=C3)C(=O)N4[C@]1(CCC4)[H])C(=O)[C@@](NC(=O)[C@@H]5C=C6C=7C=8C(C[C@]6(N(C)C5)[H])=CNC8C=CC7)(C)O2.[C@@H]([C@H](C(O)=O)O)(C(O)=O)O
Synonyms:
  • (5'Alpha)-5'-Benzyl-12'-Hydroxy-2'-Methyl-3',6',18-Trioxoergotaman 2,3-Dihydroxybutanedioate (1:1)
  • (5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)-Ergotaman-3',6',18-trione, [R-(R*,R*)]-2,3-dihydroxybutanediate (2:1) (salt)
  • Ergam
  • Ergate
  • Ergomar
  • Ergostat
  • Ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'alpha)-, [R-(R*,R*)]-2,3-dihydroxybutanedioate (2:1) (salt)
  • Ergotaman-3′,6′,18-trione, 12′-hydroxy-2′-methyl-5′-(phenylmethyl)-, (5α)-, (2R,3R)-2,3-dihydroxybutanedioate (2:1)
  • Ergotaman-3′,6′,18-trione, 12′-hydroxy-2′-methyl-5′-(phenylmethyl)-, (5′α)-, (2R,3R)-2,3-dihydroxybutanedioate (2:1) (salt)
  • Ergotaman-3′,6′,18-trione, 12′-hydroxy-2′-methyl-5′-(phenylmethyl)-, (5′α)-, [R-(R*,R*)]-2,3-dihydroxybutanedioate (2:1) (salt)
  • See more synonyms
Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 9 products.
  • Ergotamine Tartrate

    Controlled Product
    CAS:
    Molecular weight:656.70

    Ref: 3U-X8164

    250mg
    793.00€
  • Ergotamine Tartrate

    Controlled Product
    CAS:
    Color and Shape:Neat

    Ref: 86-MM0097.00

    250mg
    270.00€
  • Ergotamine D-Tartrate

    Controlled Product
    CAS:
    Color and Shape:Neat

    Ref: LP-ERG-803-TA-10

    10mg
    378.00€
    50mg
    1,631.00€
    100mg
    To inquire
  • Ergotamine D-tartrate

    Controlled Product
    CAS:
    <p>Ergotamine D-tartrate is a drug that belongs to the group of nonsteroidal anti-inflammatory drugs. It is used in the treatment of migraine and other headaches. Ergotamine D-tartrate inhibits the production of nitric oxide, which has been shown to be involved in the process of angiogenesis. This drug also has long-term efficacy for headaches and migraines, as well as an anti-migraine effect. Ergotamine D-tartrate binds to specific receptors on neurons called alpha2 adrenergic receptors, which are located on blood vessels in the brain and have been implicated in migraine pathophysiology. These receptors are not present on vessels elsewhere in the body, which makes ergotamine a more selective drug for migraine than other nonsteroidal anti-inflammatory drugs.</p>
    Formula:(C33H35N5O5)2•C4H6O6
    Purity:Min. 95%
    Molecular weight:1,313.44 g/mol

    Ref: 3D-FE30656

    1g
    940.00€
    50mg
    184.00€
    100mg
    240.00€
    250mg
    433.00€
    500mg
    657.00€
  • ERGOTAMINE TARTRATE CRS - * DRUG PRECURSOR

    Controlled Product
    CAS:
    ERGOTAMINE TARTRATE CRS - * DRUG PRECURSOR
    Formula:C70H76N10O16
    Color and Shape:Powder
    Molecular weight:1313.41

    Ref: 41-E1200000

    100mg
    115.00€
  • ERGOTAMINE FOR SYSTEM SUITABILITY CRS - * DRUG PRECURSOR (ERGOTAMINE TARTRATE)

    Controlled Product
    CAS:
    ERGOTAMINE FOR SYSTEM SUITABILITY CRS - * DRUG PRECURSOR (ERGOTAMINE TARTRATE)
    Formula:C70H76N10O16
    Color and Shape:Powder
    Molecular weight:1313.41

    Ref: 41-Y0001851

    10mg
    115.00€
  • ERGOTAMINE TARTRATE RS - * DRUG PRECURSOR

    Controlled Product
    CAS:
    ERGOTAMINE TARTRATE RS - * DRUG PRECURSOR
    Formula:C70H76N10O16
    Color and Shape:Powder
    Molecular weight:1313.41

    Ref: 41-ICRS0297

    50mg
    102.00€
  • Ergotamine Tartrate

    Controlled Product
    CAS:
    Ergotamine and its salts
    Formula:(C33H35N5O5)2·C4H6O6
    Color and Shape:White Yellow Powder
    Molecular weight:1162.52764
  • Ergotamine tartrate

    Controlled Product
    CAS:
    Ergotamine tartrate
    Color and Shape:White

    Ref: 47-141

    200mg
    Discontinued
    Discontinued product